Abbott reports more HeartMate LVAD problems
Abbott's problems with its HeartMate LVADs continue to grow, this time involving system monitors.
Stay updated with breaking news from Heartmate Touch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott's problems with its HeartMate LVADs continue to grow, this time involving system monitors.
The HeartMate Touch Communication System (version 1.0.32) is being recalled because the pump may unexpectedly stop or start.
The U.S. Food and Drug Administration (FDA) announced that Abbott is recalling its HeartMate Touch System (version 1.0.32) for risk of unexpected pump stop or start. Issues may occur if the HeartMate Touch System is disconnected from a patient’s HeartMate Controller while a “pump stop” command is running. People who have the implantable HeartMate 3 Left Ventricular Assist Device may be affected.
The FDA deemed a recall of the Abbott (NYSE:ABT) HeartMate Touch Communication System Class I, the most serious kind of recall.
Abbott became the dominant provider of left ventricular assist devices (LVADs) after Medtronic's decision last year to leave the market.